Cite Filings / FHTX / 9999999997-20-005173

Feed Companies Filings Check

Sign in

SEC STAFF LETTER

SEC Staff Letter Redacted Exhibit

Foghorn Therapeutics Inc. Filed 2020-10-29 Acc 9999999997-20-005173

Documents 1

SEC STAFF LETTER SEC Staff Letter Redacted Exhibit , filename1.pdf

Around this filing

2020-10-29 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2020-10-29 SC 13D Beneficial Ownership Report
2020-10-29 4 Chief Scientific Officer bought 5,500 shares at $16.00 ($88,000)
2020-10-29 4 See Remarks acquired 25,225 shares (conversion)
2020-10-29 4 10% owner bought 150,000 shares at $16.00 ($2,400,000)
2020-10-28 4 Former 10% Owner bought 150,000 shares at $16.00 ($2,400,000)
2020-10-20 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading filename1.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…